Imunon, Inc. (NASDAQ:IMNN) Q4 2023 Earnings Call Transcript

Imunon, Inc. beats earnings expectations. Reported EPS is $-0.52, expectations were $-0.59. Imunon, Inc.

Related Keywords

New Jersey ,United States ,Alabama ,Boston ,Massachusetts ,Texas ,Oklahoma ,Israel ,Brookline ,Pennsylvania ,Philadelphia ,Jeff Church ,Sloan Kettering ,Kim Golodetz ,Michael Tardugno ,David Bautz ,Laura Suriel ,Kemp Dolliver ,Johns Hopkins ,James Molloy ,Corinne Le Goff ,Le Goff ,Oklahoma University ,It Dm Clinical Research ,Imunon Inc ,Silicon Valley Bank ,Exchange Commission ,Alliance Global Partners ,Hudson Technology Finance Corporation ,Jeffrey Church ,University Of Texas Md Anderson Cancer Center ,Hudsonalpha Institute In Huntsville ,Breakthrough Cancer Foundation ,Nasdaq ,Dm Clinical Research ,Call Transcript March ,Results Conference ,Chief Financial Officer ,Sebastien Hazard ,Chief Medical ,Kursheed Anwer ,Chief Science Officer ,Hudsonalpha Institute ,Beth Israel ,Memorial Sloan Kettering ,Silicon Valley ,Hudson Technology Finance ,Obese Countries ,Alliance Global ,Anwer Kursheed ,Brookline Capital ,Targeted Product Profile ,